-
Press Room
-
Press Releases
-
Dec 17, 2012
6:30 AM
Volition Launches NuQ® Epigenetic Immunoassays for Research Use
-
Aug 21, 2012
7:30 AM
VolitionRX to Begin Prospective Clinical Trial in Colon Cancer
-
Jul 16, 2012
7:30 AM
VolitionRX Issues CEO Letter to Shareholders
-
Jul 09, 2012
7:30 AM
VolitionRX Signs Collaboration Agreement With Stefan Holdenrieder of Rheinische Friedrich-Wilhelms-Universitat Bonn Germany
-
May 14, 2012
9:00 AM
VolitionRX Raises Over $1 Million To Begin Clinical Trials of Blood Based Diagnostic Tests
-
Mar 27, 2012
8:01 PM
Pioneering New Science Nucleosomics Advances Blood Based Diagnostics for Cancer
-
Feb 17, 2012
5:00 AM
Volition Signs Collaboration Agreement With Abcodia